Giuseppe Giaccone

Biography

"Prof. G. Giaccone, MD, PhD, is the Associate Director for Clinical Research at the Lombardi Comprehensive Cancer Center of the Georgetown Univerissity in Washington DC, USA. He was the Chief of the Medical Oncology Branch of the National Cancer Institute, NIH, Bethesda MD, USA until the end of December 2012. Dr. Giaccone is an internationally recognized expert in the field of lung cancer and developmental therapeutics, helping to develop new chemotherapies and new strategies of anticancer treatment, in particular with targeted agents that work specifically on cancer cells. His medical training was at the Turin medical school, Italy. He then spent two years in the NCI's Medical Oncology Branch under the direction of Dr John Minna from 1988 to 1990. Following his training at the NCI, Dr. Giaccone moved to the Free University Medical Center in Amsterdam, the Netherlands, as senior medical oncologist and he was appointed Professor of Medical Oncology in 2000, and head of the department of Medical Oncology of the Medical Center in 2003. He played a major role in the European Organization for Research and Treatment of Cancer (EORTC), serving as Chair of the EORTC's Lung Cancer Cooperative Group from 1993 to 2000. During his leadership of this Group, Prof. Giaccone led several major clinical studies focusing on lung cancer and mesothelioma. In 2007 he moved back to the US National Cancer Institute, to lead the Medical Oncology Branch. In January 2013 he moved to Georgetown University where he presently leads the Thoracic Oncology secition, co-chairs the Experimental Therapeutics Program and is Director of Clinical Research for the MedStar Network. He is Professor of Medical Oncology and Pharmacology. He has published more than 500 peer-reviewed papers and contributed to more than 30 book chapters. The major areas of research are in the biology and treatment of lung cancer, thymic malignancies and drug development. "

Research Interest

lung cancerThymic malignanciesDrug Developmentcancer geneticstargeted therapyoncologyTherapeuticsCancerchemotherapyHereditary cancermolecular targetsCell Cycle ProteinsChromosomal Proteins, Non-HistoneChromosomes, HumanColorectal Neoplasms